Effect and Prognosis Factors of Combining Laparoscopic Radical Resection of Colon Adenocarcinoma with Docetaxel Therapy in Treating Middle and Advanced Colon Adenocarcinoma

Figure 1

Comparison of patients’ serum tumor marker levels before and after treatment (mean ± SD). (a) the comparison of serum CEA level values of patients with middle and advanced COAD before and after treatment, the horizontal axis indicated before treatment and after treatment, and the vertical axis indicated the CEA level value (ng·mL⁻¹); before and after treatment, the mean serum CEA level values of patients with middle and advanced COAD were, respectively, (23.62 ± 2.65) and (10.42 ± 1.51); significant difference in the mean serum CEA level values of patients with middle and advanced COAD before and after treatment (t = 43.923, ); (b) the comparison of serum CA125 level values of patients with middle and advanced COAD before and after treatment, the horizontal axis indicated before treatment and after treatment, and the vertical axis indicated the CA125 level value (U·mL⁻¹); before and after treatment, the mean serum CA125 level values of patients with middle and advanced COAD were, respectively, (127.05 ± 4.68) and (72.72 ± 2.36); significant difference in the mean serum CA125 level values of patients with middle and advanced COAD before and after treatment (t = 105.199, ); (c) the comparison of serum CA19-9 level values of patients with middle and advanced COAD before and after treatment, the horizontal axis indicated before treatment and after treatment, and the vertical axis indicated the serum CA19-9 level value (U·mL⁻¹); before and after treatment, the mean serum CA19-9 level values of patients with middle and advanced COAD were, respectively, (80.67 ± 5.03) and (39.24 ± 3.65); significant difference in the mean serum CA19-9 level values of patients with middle and advanced COAD before and after treatment (t = 67.656, ).

(a)

(b)

(c)